Boston Scientific - 33 Year Stock Price History | BSX
Historical daily share price chart and data for Boston Scientific since 1992 adjusted for splits and dividends. The latest closing stock price for Boston Scientific as of July 17, 2025 is 104.65.
- The all-time high Boston Scientific stock closing price was 107.41 on June 30, 2025.
- The Boston Scientific 52-week high stock price is 107.53, which is 2.8% above the current share price.
- The Boston Scientific 52-week low stock price is 71.88, which is 31.3% below the current share price.
- The average Boston Scientific stock price for the last 52 weeks is 93.40.
| Boston Scientific Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 101.1912 | 89.3800 | 107.4100 | 89.3800 | 104.6500 | 17.16% |
| 2024 | 76.2402 | 57.8400 | 91.5000 | 57.6000 | 89.3200 | 54.51% |
| 2023 | 51.3086 | 46.0100 | 57.8100 | 45.0900 | 57.8100 | 24.94% |
| 2022 | 41.8571 | 43.1200 | 47.2000 | 35.2400 | 46.2700 | 8.92% |
| 2021 | 41.5873 | 35.2700 | 45.8800 | 35.2700 | 42.4800 | 18.16% |
| 2020 | 37.4060 | 45.3300 | 45.7100 | 25.8300 | 35.9500 | -20.50% |
| 2019 | 40.2481 | 34.4600 | 45.3700 | 32.9100 | 45.2200 | 27.96% |
| 2018 | 32.1653 | 25.2800 | 39.0400 | 25.2000 | 35.3400 | 42.56% |
| 2017 | 26.5221 | 21.8800 | 29.8000 | 21.8800 | 24.7900 | 14.61% |
| 2016 | 21.2597 | 17.9900 | 24.4800 | 16.0700 | 21.6300 | 17.30% |
| 2015 | 17.1850 | 13.2200 | 18.9400 | 13.2200 | 18.4400 | 39.17% |
| 2014 | 12.8728 | 11.9100 | 13.9800 | 11.3700 | 13.2500 | 10.23% |
| 2013 | 9.6037 | 5.8900 | 12.3800 | 5.8900 | 12.0200 | 109.77% |
| 2012 | 5.6996 | 5.3600 | 6.3600 | 4.9700 | 5.7300 | 7.30% |
| 2011 | 6.5927 | 7.6000 | 7.7900 | 5.0900 | 5.3400 | -29.46% |
| 2010 | 6.7475 | 9.0100 | 9.6200 | 5.1300 | 7.5700 | -15.89% |
| 2009 | 9.1606 | 7.8800 | 11.7500 | 6.1400 | 9.0000 | 16.28% |
| 2008 | 11.5123 | 11.4100 | 14.1100 | 5.4800 | 7.7400 | -33.45% |
| 2007 | 14.7927 | 16.9100 | 18.5900 | 11.4700 | 11.6300 | -32.31% |
| 2006 | 19.1086 | 24.4600 | 26.4800 | 14.6500 | 17.1800 | -29.85% |
| 2005 | 28.2739 | 34.2900 | 35.1900 | 22.9500 | 24.4900 | -31.11% |
| 2004 | 38.7842 | 36.2500 | 45.8100 | 32.1200 | 35.5500 | -3.29% |
| 2003 | 28.0459 | 21.4950 | 36.7600 | 19.8350 | 36.7600 | 72.91% |
| 2002 | 14.7091 | 11.3750 | 22.1050 | 10.5550 | 21.2600 | 76.29% |
| 2001 | 9.5295 | 6.7500 | 13.8400 | 6.7500 | 12.0600 | 76.22% |
| 2000 | 9.8015 | 11.5000 | 14.1563 | 6.1250 | 6.8438 | -37.43% |
| 1999 | 15.8605 | 13.2188 | 23.2500 | 8.9063 | 10.9375 | -18.42% |
| 1998 | 15.4836 | 11.5625 | 20.2813 | 10.5938 | 13.4063 | 16.89% |
| 1997 | 14.8515 | 14.8438 | 19.2500 | 10.3906 | 11.4688 | -23.54% |
| 1996 | 12.1729 | 11.9375 | 15.2500 | 9.7813 | 15.0000 | 21.83% |
| 1995 | 8.0433 | 4.1875 | 12.3125 | 4.1875 | 12.3125 | 183.45% |
| 1994 | 3.7647 | 3.0000 | 4.4063 | 3.0000 | 4.3438 | 39.00% |
| 1993 | 3.6875 | 5.2813 | 5.7813 | 2.4063 | 3.1250 | -40.12% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $154.824B | $16.747B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Medtronic (MDT) | Ireland | $114.826B | 16.28 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Insulet (PODD) | United States | $19.948B | 78.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| Neogen (NEOG) | United States | $1.055B | 13.50 |
| BioLife Solutions (BLFS) | United States | $1.025B | 0.00 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |